Dr. Anette V. Nieves, MD

Dr. Nieves practices at Neurological Specialists Of Central Florida in Ocala, Florida.

Dr. Nieves' NPI, 1770658957, was assigned on November 22, 2006. Dr. Nieves graduated from University of Puerto Rico, Medical Sciences Campus in 1995. Dr. Nieves holds Florida license ME 98789.

Dr. Nieves' primary practice is Neurological Specialists of Central Florida, at 1724 Se 17th Ave, Ocala, FL 34471-4623. The practice phone is (352) 901-6210.

Dr. Nieves' primary practice is Neurological Specialists Of Central Florida in Ocala, Florida. Dr. Nieves is also affiliated with AdventHealth Ocala. The medical group on file is Neurological Specialists of Central Florida. Dmand AI also links Dr. Nieves to 1 more hospital, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nieves practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nieves' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Nieves' licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists alzheimer's disease, epilepsy, essential tremor, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment and neuropathy among the conditions Dr. Nieves treats.

CMS data shows 15,599 Medicare services from Dr. Nieves across 15 procedure codes in 2024, for 867 Medicare patients. Medicare paid $331,803 for them. Every service was in an office.

CMS counts 867 Medicare patients who saw Dr. Nieves in 2024. The largest group is 75 to 84, with 508 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nieves' median patient age at 78, with 45% women.

In 2024, Dr. Nieves wrote 6,158 Medicare Part D claims for 941 patients. 94% of them were for generic drugs. CMS names the drug for 5,943 of them, across 61 drugs with 11 or more claims each, at $1,526,964 in total drug cost. In 2023, CMS named 5,122 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nieves for performance year 2024, reported individually. Dr. Nieves accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nieves as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Nieves in 2016. The most frequent topics are Parkinson Disease. Dr. Nieves' most frequent co-authors are Andrew Peter Duker, MD, Aaron L. Ellenbogen, DO and Eric Scott Farbman, MD.

Dmand AI links Dr. Nieves to 7 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Alzheimer Disease, Migraine Disorders and Parkinson Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Nieves that name 2 trials.

CMS Open Payments shows 497 general payments to Dr. Nieves from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $2,198. It also lists 5 research payments totaling $19,592 from 2018 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Nieves, most recently CMS Stage 1 EHR in 2013.

Dr. Nieves graduated from University of Puerto Rico, Medical Sciences Campus in 1995.

Dr. Nieves is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.